From the perspective of US-China competition, the significance is not simply that Washington wants more AI. It is that the ...

Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same ...

QRS's latest model of the world's finest player piano system, PNO4 NV, comes with the same set of industry-leading app ...

Humans&, a new startup founded by alumni of Anthropic, Meta, OpenAI, xAI, and Google DeepMind, is building the next ...

OpenAI has quietly reversed a major change to how hundreds of millions of people use ChatGPT. On a low-profile blog that tracks product changes, the company said that it rolled back ChatGPT’s model ...

In 2019 I wrote about research suggesting anti-inflammatory medications might help some people with major depression. At the time, the idea that depression could have roots in the immune system felt ...

The Food and Drug Administration plans to select about 40 devices not yet cleared by the agency to receive special agency discretion to participate in the new chronic care Advancing Chronic Care with ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

The Atlantic hurricane season is drawing to a close, and with the tropics quieting down for a winter slumber, the focus of forecasters turns to evaluating what worked and what did not during the ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

A new study offers hope for brain cancer patients facing memory loss from radiotherapy. By blocking a single immune receptor, scientists preserved cognition in mice without dulling the cancer-killing ...